EHRA EUROPACE 2013 - European Society of Cardiology

monday
posters
MOndAy 24 JUnE 2013 - POSTERS AFTERNOON
Moderate consumption of marine n-3 fatty acids is associated with a lower risk of atrial
fibrillation - a cohort study P636
T.A. Rix, A.M. Joensen, S. Lundbye-Christensen, S. Riahi, E.B. Schmidt, K. Overvad (Aalborg
and Aarhus, DK)
Predictors for the recurrence of atrial fibrillation: what should we really use? P637
L.V. Paiva, R. Providencia, S. Barra, A.C. Faustino, P. Dinis, J. Nascimento, A.M. Botelho,
A. Leitao-Marques (Coimbra, PT)
Pre-existent advanced interatrial block may predict atrial fibrillation recurrence after
successful pulmonary vein isolation for paroxysmal atrial fibrillation. P638
J.C. Caldwell, S. Koppikar, W. Barake, D. Redfearn, K. Michael, C. Simpson, W. Hopman,
A. Baranchuk (Kingston, CA)
Atrial fibrillation recurrence after the first episode in context of acute coronary syndrome P639
V. Ramos, C. Braga, J. Martins, C. Arantes, C. Vieira, J. Marques, A. Gaspar, P. Azevedo,
M. Alvares Pereira, A. Correia (Braga, PT)
dynamics of functional status and collagen matrix markers of arterial wall in patients with
chronic heart failure and permanent atrial fibrillation during therapy including omega-3
unsaturated fatty P640
N. Koziolova, Y. Shilova, J. Nikonova, E. Polyanskaya (Perm, RU)
Efficacy of ablation of atrial fibrillation in Brugada syndrome P641
E. Arbelo, P.M. Berne, E. Guiu, P. Ramos, P. Cabanas, D. Andreu, F. Bisbal, J. Brugada, L.L. Mont
(Barcelona, ES)
Evaluation of reduction of asymptomatic cerebral embolism (ERACE) in phased rf-ablation P642
S.G. Spitzer, A. Verma, P. Debruyne, S. Nardi, T. Deneke, Y. De Greef, J. Balzer, L. Boersma
(Dresden, Bad Neustadt an der Saale and Mainz, DE; Newmarket, CA; Bonheiden and
Antwerpen, BE; Castel Volturno, IT; Nieuwegein, NL)
Enhanced lesion formation as mechanism for higher procedural efficiency of the novel
entire-tiP irrigated Rf ablation technology tthermocool sf) in patients undergoing
pulmonary vein isolation 643 (W)
P. Schurr, C.I. Park, H. Lehrmann, R. Weber, J. Schiebeling-Roemer, J. Allgeier,
C. Herrera Siklody, D. Shah, T. Arentz, A. Jadidi (Bad Krozingen, DE; Geneva, CH)
Use of real-time 3d transoesophageal echocardiography during pulmonary vein isolation in
patients with atrial fibrillation P644
M. Acena, F. Regoli, F. Faletra, E. Faragasso, C. Klersy, A. Auricchio (Lugano, CH)
Efficiency of Heparin infusion may take more than 20 minutes during ablation of atrial fibrillation P645
V. Gabus, A. Rollin, Y. Roux, D. Graf, J. Schlaepfer, M. Fromer, P. Maury, P. Pascale, A. Forclaz,
E. Pruvot (lausanne, CH; Toulouse, FR)
Clinical predictors for late recurrences of atrial fibrillation after catheter ablation P646
J. Kornej, J. Kosiuk, A. Arya, C. Piorkowski, P. Sommer, S. Rolf, D. Husser, G. Hindricks, G. Lip,
A. Bollmann (Birmingham, GB; Leipzig, DE)
low dose rotational angiography P647
S. De Buck, B.S.N. Alzand, J.-Y. Wielandts, C. Garweg, T. Phlips, J. Ector, D. Nuyens,
H. Heidbuchel (Leuven, BE)
Concentric hypertrophy of left ventricle independently predicts atrial aibrillation recurrence
in patients treated with rhythm control strategy: a post-hoc analysis from AffiRM trial P648
N. Shah, P. Grover, N. Patel, A. Chothani, K. Mehta, A. Deshmukh, A. Badheka, H. Paydak,
R.D. Mitrani, J. Viles-Gonzalez (Staten Island, Miami, Washington, Philadelphia and Little Rock, US)
102